INVENTAA INDUSTRIES PRIVATE LTD

Overview

INVENTAA INDUSTRIES PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering AMLODIPINE BESYLATE; AMLODIPINE BESYLATE (PROCESS 1); CARBIDOPA; CETIRIZINE DIHYDROCHLORIDE; HYDROXYZINE HYDROCHLORIDE; LEVOCETIRIZINE DIHYDROCHLORIDE USP.

API / Drug Master Files

INVENTAA INDUSTRIES PRIVATE LTD holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TELMISARTANActive2023-10-13
• HYDROXYZINE HYDROCHLORIDEActive2022-11-17
• AMLODIPINE BESYLATE (PROCESS 1)Active2013-12-16
• PHTHALIMIDO AMLODIPINEActive2012-10-11
• CARBIDOPAActive2011-12-07
• RALOXIFENE HYDROCHLORIDEActive2008-06-05
• LEVOCETIRIZINE DIHYDROCHLORIDE USPActive2007-12-06
• AMLODIPINE BESYLATEActive2006-07-11
• CETIRIZINE DIHYDROCHLORIDEActive2006-01-23
• TRIMETHOPRIM USPActive2001-06-28

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to INVENTAA INDUSTRIES PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.